{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BNT162b2+Vaccine&page=2", "query": { "intervention": "BNT162b2 Vaccine", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BNT162b2+Vaccine&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-29T20:49:01.715Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05472038", "title": "A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b5 Bivalent (WT/OMI BA.2)", "type": "BIOLOGICAL" }, { "name": "BNT162b2 Bivalent (WT/OMI BA.1)", "type": "BIOLOGICAL" }, { "name": "BNT162b2 Bivalent (WT/OMI BA.4/BA.5)", "type": "BIOLOGICAL" }, { "name": "BNT162b5 Bivalent (Original/OMI BA.4/BA.5)", "type": "BIOLOGICAL" }, { "name": "BNT162b6 Bivalent (Original/OMI BA.4/BA.5)", "type": "BIOLOGICAL" }, { "name": "BNT162b7 Bivalent (Original/OMI BA.4/BA.5)", "type": "BIOLOGICAL" }, { "name": "BNT162b7 Monovalent (OMI BA.4/BA.5)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1453, "start_date": "2022-07-26", "completion_date": "2024-03-26", "has_results": true, "last_update_posted_date": "2025-10-01", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 31, "location_summary": "Anaheim, California • San Diego, California • Valley Village, California + 26 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Valley Village", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Milford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05472038" }, { "nct_id": "NCT05000216", "title": "COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis (RA)", "Systemic Lupus Erythematosus (SLE)", "Pemphigus Vulgaris", "Multiple Sclerosis (MS)", "Systemic Sclerosis (SSc)", "Pediatric SLE", "Juvenile Idiopathic Arthritis (JIA)", "Juvenile Dermatomyositis (JDM)", "Pediatric-Onset Multiple Sclerosis (POMS)" ], "interventions": [ { "name": "Moderna mRNA-1273", "type": "BIOLOGICAL" }, { "name": "BNT162b2", "type": "BIOLOGICAL" }, { "name": "Ad26.COV2.S", "type": "BIOLOGICAL" }, { "name": "Continue IS (MMF or MPA)", "type": "DRUG" }, { "name": "Continue IS (MTX)", "type": "DRUG" }, { "name": "Continue IS (B cell depletion therapy)", "type": "BIOLOGICAL" }, { "name": "Monovalent [B.1.351] CoV2 preS dTM-AS03", "type": "BIOLOGICAL" }, { "name": "Withhold IS (MMF or MPA)", "type": "DRUG" }, { "name": "Withhold IS (MTX)", "type": "DRUG" }, { "name": "Withhold IS (B cell depletion therapy)", "type": "DRUG" }, { "name": "Moderna mRNA-1273, Bivalent", "type": "BIOLOGICAL" }, { "name": "BNT162b2, Bivalent", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 258, "start_date": "2021-08-13", "completion_date": "2024-03-28", "has_results": true, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 29, "location_summary": "Los Angeles, California • New Haven, Connecticut • Atlanta, Georgia + 18 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05000216" }, { "nct_id": "NCT06672055", "title": "A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "SARS-CoV2", "COVID-19" ], "interventions": [ { "name": "VXA-CoV2-3.1", "type": "BIOLOGICAL" }, { "name": "COMIRNATY®", "type": "BIOLOGICAL" }, { "name": "VXA-CoV2-3.3", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Vaxart", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5485, "start_date": "2024-10-08", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 145, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Mobile, Alabama + 126 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06672055" }, { "nct_id": "NCT05077254", "title": "COVID Protection After Transplant-Immunosuppression Reduction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplant Recipients", "Liver Transplant Recipients" ], "interventions": [ { "name": "Pfizer-BioNTech COVID-19 Vaccine 2023-2024", "type": "BIOLOGICAL" }, { "name": "Moderna COVID-19 Vaccine 2023-2024", "type": "BIOLOGICAL" }, { "name": "SOC IS Regimen", "type": "DRUG" }, { "name": "SOC IS Reduction", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2021-12-06", "completion_date": "2025-02-21", "has_results": true, "last_update_posted_date": "2026-04-23", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 15, "location_summary": "San Diego, California • San Francisco, California • Atlanta, Georgia + 10 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Evanston", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05077254" }, { "nct_id": "NCT05876377", "title": "Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "SARS-CoV-2", "COVID-19", "Post-Acute COVID-19 Syndrome" ], "interventions": [ { "name": "Pfizer-BioNTech COVID-19 mRNA vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": 1, "start_date": "2023-10-23", "completion_date": "2026-05-31", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05876377" }, { "nct_id": "NCT04969263", "title": "COVID-19 Protection After Transplant Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplant Recipients" ], "interventions": [ { "name": "BNT162b2 vaccine (Pfizer/BioNTech)", "type": "BIOLOGICAL" }, { "name": "mRNA-1273 vaccine (Moderna)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 81, "start_date": "2021-08-10", "completion_date": "2023-03-10", "has_results": true, "last_update_posted_date": "2025-07-30", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04969263" }, { "nct_id": "NCT07390968", "title": "Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hematopoietic and Lymphatic System Neoplasm" ], "interventions": [ { "name": "SARS-CoV-2 mRNA Vaccine ARCT-021", "type": "BIOLOGICAL" }, { "name": "Tozinameran", "type": "BIOLOGICAL" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "OTHER" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 56, "start_date": "2026-12-01", "completion_date": "2029-01-01", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07390968" }, { "nct_id": "NCT04999111", "title": "A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronavirus Disease" ], "interventions": [ { "name": "Ad26.COV2.S", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Janssen Vaccines & Prevention B.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1541, "start_date": "2021-08-06", "completion_date": "2022-11-22", "has_results": true, "last_update_posted_date": "2025-02-04", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Anaheim, California + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "North Hollywood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04999111" }, { "nct_id": "NCT05007860", "title": "Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma" ], "interventions": [ { "name": "PCV13 vaccine and any of the FDA-approved COVID-19 vaccine products (BNT162b2, mRNA-1273, or Ad26.COV2.S) based on local availability.", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2020-07-16", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2023-07-07", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05007860" }, { "nct_id": "NCT07730450", "title": "A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COVID-19 Vaccines" ], "interventions": [ { "name": "BNT162b2 Vaccine", "type": "BIOLOGICAL" }, { "name": "Tdap Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 200, "start_date": "2026-07-23", "completion_date": "2027-08-20", "has_results": false, "last_update_posted_date": "2026-08-07", "last_synced_at": "2026-09-29T20:49:01.715Z", "location_count": 5, "location_summary": "Walnut Creek, California • Miami Lakes, Florida • Honolulu, Hawaii + 2 more", "locations": [ { "city": "Walnut Creek", "state": "California" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Honolulu", "state": "Hawaii" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07730450" } ] }